Healthcare in 2026 is entering a pivotal era—one defined not by hype, but by measurable impact, financial pressure, and accelerated innovation. According to McKinsey, the U.S. healthcare industry continues to face significant strain, with EBITDA as a percentage of national health expenditures dropping from 11.2% in 2019 to 8.9% in 2024, and projected to fall